4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001209191-18-055379
Director acquired 18,716 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Kazam Joshua A · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-10-15 | Conversion : show line 1 in the form | +18,716 | 1,390,651 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-10-15 | Conversion : show line 2 in the form Series A Convertible Preferred Stock | −3,565 | 0 | D |
Loading xslF345X03/doc4.xml…